Observational studyJournal of thrombosis and thrombolysis2020

Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care.

Markus Gulilat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.